Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:CPSR

Capstar Special Purpose Acquisition (CPSR) Stock Price, News & Analysis

Capstar Special Purpose Acquisition logo

About Capstar Special Purpose Acquisition Stock (NYSE:CPSR)

Key Stats

Today's Range
$6.00
$8.24
50-Day Range
$6.53
$9.99
52-Week Range
$6.06
$12.23
Volume
237,378 shs
Average Volume
556,189 shs
Market Capitalization
$225.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Capstar Special Purpose Acquisition Corp. is a blank check company. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the consumer, healthcare, and technology, media and telecommunications industries. The company was incorporated in 2020 and is based Austin, Texas.

Receive CPSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstar Special Purpose Acquisition and its competitors with MarketBeat's FREE daily newsletter.

CPSR Stock News Headlines

Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration.
CSTR CapStar Financial Holdings, Inc.
Sk No 5 Special Purpose Acquisition (337450)
See More Headlines

CPSR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Capstar Special Purpose Acquisition investors own include Pfizer (PFE), Banco Bilbao Vizcaya Argentaria (BBVA), Exact Sciences (EXAS), Atlantic Avenue Acquisition (ASAQ), Bank of America (BAC), Broadstone Acquisition (BSN) and CITIC Capital Acquisition (CCAC).

Company Calendar

Today
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($1.18) per share

Miscellaneous

Free Float
N/A
Market Cap
$225.29 million
Optionable
Not Optionable
Beta
0.07
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NYSE:CPSR) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners